Clinical Trials Logo

Clinical Trial Summary

The aim of the study is to evaluate the polymerase chain reaction (PCR)-Reverse Blot Hybridization Assay (REBA) for identification of nontuberculous mycobacteria (NTM) species in acid-fast bacilli (AFB) smear-positive respiratory specimens.


Clinical Trial Description

n/a


Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT00999076
Study type Observational
Source Samsung Medical Center
Contact
Status Terminated
Phase N/A
Start date September 2009
Completion date December 2011

See also
  Status Clinical Trial Phase
Completed NCT04874948 - Absorption, Elimination and Safety of 14C-labeled Radioactive BTZ-043, a New Compound in TB Treatment Phase 1
Completed NCT00004276 - Phase II Placebo Controlled Study of Thalidomide in Patients With Mycobacterial and HIV Infections Phase 2
Recruiting NCT05610098 - Gene Expression Profiles in Spinal Tuberculosis.
Recruiting NCT02913365 - Etiologies, Investigations and Outcomes of Patients Presenting With Hemoptysis N/A
Recruiting NCT06155747 - Transmission and Acquisition of Nontuberculous Mycobacteria Outbreak Investigation (TrANsMIt)
Completed NCT03590600 - A Single Ascending Dose Study of BTZ043 Phase 1
Recruiting NCT01212003 - Training Protocol on the Natural History of Tuberculosis
Completed NCT01547884 - Effect of Filarial Infection on Immune Responses in Latent Tuberculosis
Recruiting NCT00018044 - Study of Mycobacterial Infections
Enrolling by invitation NCT06262282 - Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria
Recruiting NCT06266442 - M. Avium WGS During Mav-PD Treatment
Recruiting NCT05824988 - Drug Exposure and Minimum Inhibitory Concentration in the Treatment of MAC Lung Disease